Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
基本信息
- 批准号:8080463
- 负责人:
- 金额:$ 51.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-30 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:8-hydroxy-2&apos-deoxyguanosine8-hydroxyguanosineAccountingAdverse effectsAlbuminsAlcohol abuseAlcohol consumptionAlcoholic Liver DiseasesAlcoholic liver damageAlcoholismAlcoholsAnti-Retroviral AgentsAntioxidantsBilirubinBloodBlood PlateletsBlood specimenCD4 Lymphocyte CountCaroteneCell CountCharacteristicsChronicClinicClinic VisitsClinical TrialsComorbidityConsentDNADNA DamageDiseaseDisease ProgressionDropsEatingEffectivenessEnrollmentFamilyFastingGlutathioneHIVHIV InfectionsHIV-1HepaticHepatocellular DamageHepatotoxicityHyaluronic AcidInjuryInterventionLifeLipid PeroxidationLiverLiver DysfunctionLiver diseasesLongitudinal StudiesMalnutritionMalondialdehydeMediatingMental disordersMicronutrientsMitochondriaMitochondrial DNANucleosidesObesityOxidative StressParticipantPathologyPatientsPersonsPharmaceutical PreparationsPlasmaPlayPloidiesPreventiveProtease InhibitorProteinsQuestionnairesRNARecruitment ActivityReverse Transcriptase InhibitorsSeleniumSeveritiesStagingSystemTestingTherapeuticToxic effectTreatment outcomeViral Load resultVisitVitamin AZincalcohol abstinencealcohol effectantiretroviral therapybasechronic alcohol ingestioncohortdemographicsdrinkingfollow-upimprovednovel therapeuticsoxidationoxidative damagepreventproblem drinkerpublic health relevancetransmission process
项目摘要
DESCRIPTION (provided by applicant): Chronic alcohol consumption is associated with increased hepatic oxidative stress and reduced antioxidant defense resulting in alcohol-induced liver injury. Nucleoside reverse transcriptase inhibitors (NRTI) in combination with non-NRTIs and protease inhibitors have demonstrated their effectiveness as antiretroviral drugs against HIV-1 despite their well-described side-effects, including liver toxicity. While these side-effects are multi-factorial, oxidative stress and mitochondrial DNA damage has been suggested to play a key role. Mitochondrial DNA damage and increased oxidative stress produced by antiretroviral treatment (ART) may be aggravated by alcoholism, as chronic alcohol consumption is associated with increased hepatic oxidative stress and reduced antioxidant defense resulting in alcohol-induced liver injury. We propose to follow a cohort of 260 HIV infected ART naive participants, 65 patients who are being initiated on ART and are heavy alcohol users (Group 1), 65 patients who are being initiated on ART and do not drink alcohol or are moderate alcohol drinkers (Group 2), 65 patients who are early in HIV disease and are not being initiated on ART and are heavy alcohol users (Group 3), 65 patients who are early in HIV disease and are not being initiated on ART and do not drink alcohol or are moderate alcohol drinkers (Group 4), for 2 years. HIV staging (CD4 and viral load) co- morbidities, ART and other treatments will be documented. Questionnaires on demographics, BMI, food intake, and use of micronutrient supplements will be obtained and treated as covariates. ART will be restricted, and co-morbid conditions which are associated with oxidative stress, will be excluded before the baseline visit. Blood will be drawn for oxidative stress (malondialdehyde to indicate lipid peroxidation, protein carbonyls for protein oxidation, 8-hydroxyguanosine for DNA oxidation). Mitochondrial damage will be assessed with quantitative and qualitative changes in mitochondrial DNA content and with plasma lactate. Hepatocellular injury and function will be determined with plasma levels of ALT, AST, platelets, albumin, hyaluronic acid and total and conjugated bilirubin. Plasma antioxidants (glutathione, vitamins A and E, 1 and 2-carotenes, zinc and selenium) will also be determined. This proposal will determine the combined effects of chronic alcohol consumption and antiretroviral therapy on oxidative stress, antioxidant status, mitochondrial toxicity and liver dysfunction to provide the basis for potential preventive therapeutic approaches to protect the liver from alcohol and antiretroviral drug induced injury.
PUBLIC HEALTH RELEVANCE: The objective of this proposal is to determine the combined effects of chronic alcohol consumption and antiretroviral therapy on oxidative stress, antioxidant status, mitochondrial toxicity and liver dysfunction, and to determine the effect of increased oxidative stress and nutritional deficiencies that might occur with chronic alcoholism on HIV-associated mitochondrial DNA damage. A better appreciation for alcohol's effects on HIV and liver disease may increase utilization of alcohol cessation interventions, thus improving treatment outcomes and providing the basis for potential preventive therapeutic approaches to protect liver from alcohol and antiretroviral drug-induced liver injury.
描述(由申请人提供):慢性酒精消耗与肝氧化应激增加和抗氧化剂防御减少有关,从而导致酒精引起的肝损伤。核苷逆转录酶抑制剂(NRTI)与非NRTIS和蛋白酶抑制剂结合使用,尽管其描述良好的副作用,包括肝毒性,但它们作为针对HIV-1的抗逆转录病毒药物的有效性。尽管这些副作用是多因素的,但已建议氧化应激和线粒体DNA损伤起关键作用。酒精中毒可能会加剧线粒体DNA损伤和抗逆转录病毒治疗(ART)产生的氧化应激(ART),因为慢性酒精消耗与肝氧化应激的增加有关,抗氧化剂减少了抗氧化剂防御,导致酒精诱导的肝损伤。我们建议遵循由260名HIV感染的ART参与者组成的同类,有65名患者是在艺术上发起的,是重型酒精使用者(第1组),有65名患者是在艺术上发起的,不喝酒或中度饮酒者或中度饮酒者(第2组),在HIV疾病中且不在Art and Art和65例患者(65例)中(65例),而不是Art和65患者(65例),而不是65例,而不是65例(65例)。喝酒或中度饮酒者(第4组),持续2年。将记录HIV分期(CD4和病毒载荷)共同病毒,ART和其他治疗方法。将获取有关人口统计,BMI,食物摄入量以及微量营养补充剂的使用问卷,并将其视为协变量。将受到限制,并在基线访问之前排除与氧化应激相关的合并条件。血液将用于氧化应激(丙二醛表明脂质过氧化,蛋白羰基用于蛋白质氧化,8-羟基鸟苷用于DNA氧化)。线粒体损伤将通过线粒体DNA含量和血浆乳酸的定量和定性变化进行评估。肝细胞损伤和功能将由血浆,AST,血小板,白蛋白,透明质酸以及总和共轭胆红素的血浆水平确定。还将确定血浆抗氧化剂(谷胱甘肽,维生素A和E,1和2-偶然,锌和硒)。该提案将确定慢性酒精消耗和抗逆转录病毒疗法对氧化应激,抗氧化剂状态,线粒体毒性和肝功能障碍的综合作用,为潜在的预防性治疗方法提供了保护肝脏免受酒精和抗雷神病毒药物诱导损伤的基础。
公共卫生相关性:该提案的目的是确定慢性酒精消耗和抗逆转录病毒治疗对氧化应激,抗氧化剂状态,线粒体毒性和肝功能障碍的综合作用,并确定氧化应激和营养不足的氧化应激和营养缺乏症的影响。对酒精对艾滋病毒和肝病的影响的更好欣赏可能会增加对酒精停止干预措施的利用,从而改善治疗结果,并为潜在的预防性治疗方法提供了保护肝脏免受酒精和抗逆转录病毒药物诱导的肝损伤的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marianna K Baum其他文献
P23-032-23 Associations Between Antidepressant Use and Fasting Blood Glucose Levels in People Living With and Without HIV
- DOI:
10.1016/j.cdnut.2023.100144 - 发表时间:
2023-07-01 - 期刊:
- 影响因子:
- 作者:
Stephanie Gieseken;Quingyun Liu;Marianna K Baum;Haley R Martin;Jupshy Jasmin;Angelique Johnson;Sabrina Sales Martínez;Leslie Seminario;Jose Bastida Rodriguez - 通讯作者:
Jose Bastida Rodriguez
Marianna K Baum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marianna K Baum', 18)}}的其他基金
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
- 批准号:
10544758 - 财政年份:2022
- 资助金额:
$ 51.22万 - 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
- 批准号:
10447463 - 财政年份:2022
- 资助金额:
$ 51.22万 - 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
- 批准号:
9927614 - 财政年份:2015
- 资助金额:
$ 51.22万 - 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
- 批准号:
9144756 - 财政年份:2015
- 资助金额:
$ 51.22万 - 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
- 批准号:
9494556 - 财政年份:2015
- 资助金额:
$ 51.22万 - 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究
- 批准号:
10662839 - 财政年份:2015
- 资助金额:
$ 51.22万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
7590839 - 财政年份:2008
- 资助金额:
$ 51.22万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
8278027 - 财政年份:2008
- 资助金额:
$ 51.22万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
7857921 - 财政年份:2008
- 资助金额:
$ 51.22万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
7691806 - 财政年份:2008
- 资助金额:
$ 51.22万 - 项目类别:
相似国自然基金
基于核酸适配体-纳米胶束的荧光多标记生物传感器检测8-羟基-2'-脱氧鸟苷
- 批准号:21507020
- 批准年份:2015
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
乙型肝炎病毒X蛋白促进8-OHdG介导的致肝细胞DNA突变作用及机制
- 批准号:81572007
- 批准年份:2015
- 资助金额:75.0 万元
- 项目类别:面上项目
孕妇对环境内分泌干扰物的暴露、来源解析及健康风险评价
- 批准号:21577050
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
电喷雾解吸/萃取电离质谱快速检测尿中羟基多环芳烃研究
- 批准号:21107066
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
DNA氧化损伤标志物8-羟基脱氧鸟苷的高灵敏、高选择性电化学检测及其应用研究
- 批准号:21075059
- 批准年份:2010
- 资助金额:38.0 万元
- 项目类别:面上项目
相似海外基金
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
- 批准号:
8420439 - 财政年份:2009
- 资助金额:
$ 51.22万 - 项目类别:
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
- 批准号:
8297360 - 财政年份:2009
- 资助金额:
$ 51.22万 - 项目类别:
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
- 批准号:
8601204 - 财政年份:2009
- 资助金额:
$ 51.22万 - 项目类别:
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
- 批准号:
8788960 - 财政年份:2009
- 资助金额:
$ 51.22万 - 项目类别:
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
辅酶 Q10/泛醌 E 预清单 HD 的前传研究导致预防性试验
- 批准号:
7942954 - 财政年份:2008
- 资助金额:
$ 51.22万 - 项目类别: